Bausch Health exits Medicaid, 340B programs. Will other drugmakers follow?
In an unexpected move, Bausch Health recently stopped participating in Medicaid and a federal government drug discount scheme…
US-China Trade Deal Optimism Boosts Risk Assets: Markets Wrap – Bloomberg
US-China Trade Deal Optimism Boosts Risk Assets: Markets Wrap BloombergAsia markets mostly slip as investors look to Trump-Takaichi meeting…
Trump’s DHS is recruiting ICE officers with a Halo meme
After using the original Pokémon theme song in a montage of ICE raids, the Department of Homeland Security…
ExxonMobil accuses California of violating its free speech
ExxonMobil is suing California over state laws that compel large companies to share a more comprehensive picture of…
Trump Tariffs Deliver Shock ‘Wake-Up Call’ to a World Denim Hub
One of the world’s poorest countries is reeling from the impact of US President Donald Trump’s tariff regime,…
UK Economy Needs Growth Friendly Policy: Money Distilled
Welcome to the multi-award-winning Money Distilled newsletter. I’m John Stepek. Every week day I look at the biggest…
China Stocks Climb on Policy Readout, Upcoming Xi-Trump Meeting
Chinese stocks advanced as renewed emphasis on technological self-reliance at a key political gathering and confirmation of the…
Trump’s approach to lowering drug costs is raising questions
The Trump administration is turning to an unconventional approach to lowering drug prices in the United States: striking deals…
BOK Stands Pat on Policy as Housing Market Rally Stirs Concerns
The Bank of Korea held its benchmark interest rate steady to avoid spurring a housing market rally that…
Fed’s Loss of ADP Labor Statistics Adds to Data Vacuum
The Federal Reserve is no longer receiving data on private-sector employment from an independent provider, adding to policymakers’…
CVS Caremark tells AIDS activists Gilead needs to lower the price of its new HIV drug to get on formularies
For the past three months, CVS Caremark has resisted adding a new Gilead Sciences HIV prevention drug to…
FDA approved fewer drugs in third quarter, analysis finds
The upheaval at the Food and Drug Administration appears to be taking a toll on the pharmaceutical industry,…